Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes

Physiological Genomics

Volumn 21, Issue , 2005, Pages 222-229

  Knoll, Kristen E ^a   Pietrusz, Jennifer L ^a   Liang, Mingyu ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

CD36; Decorin; Diabetic complications; Gene expression; Microarray

Indexed keywords

CD36 ANTIGEN; DECORIN; LIM PROTEIN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; HEART LEFT VENTRICLE; KIDNEY CORTEX; LIPID METABOLISM; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ALGORITHMS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART VENTRICLES; KIDNEY CORTEX; MALE; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; STREPTOZOCIN; SULFHYDRYL COMPOUNDS; TRANSCRIPTION, GENETIC;

EID: 21244443761     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00231.2004     Document Type: Article

References (40)

1. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, and Scott J. Identification of Cd36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999.
2. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, and Ruoslahti E. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-818, 2001.
4. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193, 2000.
5. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhoffer M, Orntoft T, and Eizirik DL. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276: 48879-48886, 2001.
6. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Baseler MW, Lane HC, and Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biology 4: P3, 2003.
7. Eckenrode SE, Ruan Q, Yang P, Zheng W, McIndoe RA, and She JX. Gene expression profiles define a key checkpoint for type 1 diabetes in NOD mice. Diabetes 53: 366-375, 2004.
8. Hessner MJ, Wang X, Hulse K, Meyer L, Wu Y, Nye S, Guo SW, and Ghosh S. Three color cDNA microarrays: (quantitative assessment through the use of fluorescein-labeled probes. Nucleic Acids Res 31: e14, 2003.
9. Hessner MJ, Wang X, Khan S, Meyer L, Schlicht M, Tackes J, Datta MW, Jacob HJ, and Ghosh S. Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility. Nucleic Acids Res 31: e60, 2003.
10. Holland PM, Abramson RD, Watson R, and Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88: 7276-7280, 1991.
11. Joussen AM, Huang S, Poulaki V, Camphausen K, Beecken WD, Kirchhof B, and Adamis AP. In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci 42: 3047-3057, 2001.
12. Keen HL, Ryan MJ, Beyer A, Mathur S, Scheetz TE, Gackle BD, Faraci FM, Casavant TL, and Sigmund CD. Gene expression profiling of potential PPARgamma target genes in mouse aorta. Physiol Genomics 18: 33-42, 2004.
13. Kumar JM, Brooks DP, Olson BA, and Laping NJ. Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol 10: 2488-2494, 1999.
14. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, and Broer S. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA 97: 8157-8162, 2001.
15. Lange S, Auerbach D, McLoughlin P, Perriard E, Schafer BW, Perriard JC, and Ehler E. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J Cell Sci 115: 4925-49936, 2002.
16. Liang M, Briggs AG, Rute E, Greene AS, and Cowley AW Jr. Quantitative assessment of the importance of dye switching and biological replication in cDNA microarray studies. Physiol Genomics 14: 199-207, 2003.
17. Liang M, Cowley AW Jr, and Greene AS. High throughput gene expression profiling: a molecular approach to integrative physiology. J Physiol 554: 22-30, 2004.
18. Liang M, Cowley AW Jr, Hessner MJ, Lazar J, Basile DP, and Pietrusz JL. Transcriptome analysis and kidney research: toward systems biology. Kidney Int. In press.
19. Liang M, Croatt AJ, and Nath KA. Mechanisms underlying induction of heme oxygenase-1 by nitric oxide in renal tubular epithelial cells. Am J Physiol Renal Physiol 279: F728-F735, 2000.
20. +-ATPase in opossum kidney cells. Kidney Int 56: 627-634, 1999.
21. Liang M, Yuan B, Rute E, Greene AS, Zou AP, Soares P, McQuestion GD, Slocum GR, Jacob HJ, and Cowley AW Jr. Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study. Physiol Genomics 8: 139-149, 2002.
22. Liang M, Yuan B, Rute E, Greene AS, Olivier M, and Cowley AW Jr. Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics 12: 229-237, 2003.
23. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, and Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273, 2003.
24. Morrison J, Knoll K, Hessner MJ, and Liang M. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol Genomics 17: 271-282, 2004.
25. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, and Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 97: 11371-11376, 2000.
26. Neely JR and Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36: 413-459, 1974.
27. Polacek DC, Passerini AG, Shi C, Francesco NM, Manduchi E, Grant GR, Powell S, Bischof H, Winkler H, Stoeckert CJ Jr, and Davies PF. Fidelity and enhanced sensitivity of differential transcription profiles following linear amplification of nanogram amounts of endothelial mRNA. Physiol Genomics 13:147-156, 2003.
28. Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, Phillips LS, and Mitch WE. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 98: 1703-1708, 1996.
29. Sharma K and Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44: 1139-1146, 1995.
30. Sreekumar R, Halvatsiotis P, Schimke JC, and Nair KS. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51: 1913-1920, 2002.
31. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, and Sharma K. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004.
32. Tanahashi H and Tabira T. Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. Hum Mol Genet 9: 2281-2289, 2000.
33. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
34. Tomlinson KC, Gardiner SM, Hebden RA, and Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103-150, 1992.
35. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
36. Webb GC, Akbar MS, Zhao C, and Steiner DF. Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. Proc Natl Acad Sci USA 97: 5773-5778, 2000.
37. Wilson KH, Eckenrode SE, Li QZ, Ruan QG, Yang P, Shi JD, Davoodi-Semiromi A, McIndoe RA, Croker BP, and She JX. Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 52: 2151-2159, 2003.
38. Wilson SB, Kent SC, Horton HF, Hill AA, Bollyky PL, Hafler DA, Strominger JL, and Byrne MC. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 97: 7411-7416, 2000.
39. Yamaguchi Y, Mann DM, and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346: 281-284, 1990.
40. Yechoor VK, Patti ME, Saccone R, and Kahn CR. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc Natl Acad Sci USA 99: 10587-10592, 2002.